Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Treatment Options, Guidelines for Managing Gout Discussed at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Better understanding of goals, effect of gout therapy with nonsteroidal anti-inflammatory drugs, urate lowering medication needed to improve quality of care

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Clinical Laboratory Improvement Amendments Establish Quality Standards for Lab Tests

Staff  |  April 2, 2014

Categorization of health-assessment tests, certificates helps ensure test accuracy, reliability, and timeliness; plus, how to apply for a CLIA waiver

ACR’s Musculoskeletal Ultrasound Education Course Helps Rheumatologists Expand Skills

Staff  |  April 2, 2014

Intermediate-level program features interventional cadaver workshop, teaches latest advances, application of musculoskeletal ultrasound to help physicians evaluate, manage patients’ pain, disease states

Rheumatology Research Foundation to Play Role in Developing New RA, Lupus Treatments

Staff  |  April 2, 2014

Foundation joins Accelerating Medicines Partnership, led by National Institutes of Health, to fast-track viable potential drug therapies for lupus, rheumatoid arthritis

Coding Corner Answer: April Coding Challenge

Staff  |  April 2, 2014

ICD-10 coding for a in-office x-rays, joint injection for patient with rheumatoid arthritis

Coding Corner Question: April

Staff  |  April 2, 2014

Test your ICD-10 coding knowledge for a 51-year-old female with rheumatoid arthritis who receives in-office x-rays, joint injection

Deadline Approaches to Participate in Medicare EHR Incentive Program, aka Meaningful Use

Staff  |  April 2, 2014

2014 marks final year to reap financial benefits for adopting, implementing electronic health record system in physician practice

ARHP Member Donald R. Miller, PharmD, Named to FDA Arthritis Advocacy Committee

Staff  |  April 2, 2014

Dr. Miller, professor, chair of pharmacy practice at North Dakota State University, to evaluate new drugs seeking first-time FDA approval

  • « Previous Page
  • 1
  • …
  • 626
  • 627
  • 628
  • 629
  • 630
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences